These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34390418)

  • 1. Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic.
    Doukas PG; Patel RN; Venkatesh V; Khan SS; Baldridge A; Akhter N
    Breast Cancer Res Treat; 2021 Nov; 190(1):133-142. PubMed ID: 34390418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
    Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
    Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study.
    Kappel C; Rushton M; Johnson C; Aseyev O; Small G; Law A; Ivars J; Dent S
    Curr Oncol; 2019 Jun; 26(3):e322-e327. PubMed ID: 31285675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study.
    Fiuza M; Magalhães A; Nobre Menezes M; Costa P; Abreu Ribeiro L; Abreu C; Brás R; Vieira J; Duarte AI; Morais P; Silva B; Costa L; Pinto FJ
    Rev Port Cardiol; 2022 Dec; 41(12):979-984. PubMed ID: 36153294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of patients referred to cardio-oncology clinic].
    Liang L; An T; Zhao XM; Huang LY; Tian PC; Guan JY; Zou CH; Zhang J; Zhang YH
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2183-2186. PubMed ID: 37482731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
    Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
    Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Patients' Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs.
    Piña P; Taveras A; Khan A; Coyle J; Bueno V; Shah N; Cuello L; Collado S; Mauer A; Danciu S; Herrera CJ
    Glob Heart; 2022; 17(1):67. PubMed ID: 36199568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer.
    Kosalka P; Johnson C; Turek M; Sulpher J; Law A; Botros J; Dent S; Aseyev O
    Curr Oncol; 2019 Jun; 26(3):e314-e321. PubMed ID: 31285674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients.
    Cronin M; Lowery A; McInerney V; Wijns W; Kerin M; Keane M; Blazkova S; Neiuroukh D; Martin M; Soliman O
    Breast Cancer Res Treat; 2024 Sep; 207(2):283-291. PubMed ID: 38922547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
    Tini G; Cuomo A; Battistoni A; Sarocchi M; Mercurio V; Ameri P; Volpe M; Porto I; Tocchetti CG; Spallarossa P
    Int J Cardiol; 2022 Feb; 349():134-137. PubMed ID: 34848212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer.
    Curigliano G; de Azambuja E; Lenihan D; Calabrò MG; Cardinale D; Cipolla CM
    Oncologist; 2019 Nov; 24(11):e1034-e1043. PubMed ID: 31064888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
    Hussain Y; Drill E; Dang CT; Liu JE; Steingart RM; Yu AF
    Breast Cancer Res Treat; 2019 May; 175(1):239-246. PubMed ID: 30721443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
    Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
    Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience.
    Pareek N; Cevallos J; Moliner P; Shah M; Tan LL; Chambers V; Baksi AJ; Khattar RS; Sharma R; Rosen SD; Lyon AR
    Eur J Heart Fail; 2018 Dec; 20(12):1721-1731. PubMed ID: 30191649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic.
    Toro C; Felmingham B; Jhadav M; Celermajer DS; La Gerche A; O'Sullivan J; Kumar S; Mateos MK; Fulbright J; Govender D; Collier L; Cheung M; Eisenstat DD; Lange PW; Ayer J; Elliott DA; Conyers R
    Cardiooncology; 2023 Dec; 9(1):45. PubMed ID: 38062530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial.
    Banke A; Fosbøl EL; Møller JE; Gislason GH; Andersen M; Bernsdorf M; Jensen MB; Schou M; Ejlertsen B
    Eur J Heart Fail; 2018 Oct; 20(10):1447-1453. PubMed ID: 29493047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.
    Barron CC; Alhussein MM; Kaur U; Cosman TL; Tyagi NK; Brown M; Mukherjee SD; Ellis PM; Dhesy-Thind S; Leong DP
    Curr Oncol; 2019 Aug; 26(4):240-246. PubMed ID: 31548803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Risk and Level of Statin Use Among Women With Breast Cancer in a Cardio-Oncology Clinic.
    Shum K; Solivan A; Parto P; Polin N; Jahangir E
    Ochsner J; 2016; 16(3):217-24. PubMed ID: 27660568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer.
    Hussain M; Hou Y; Watson C; Moudgil R; Shah C; Abraham J; Budd GT; Tang WHW; Finet JE; James K; Estep JD; Xu B; Hu B; Cremer P; Jellis C; Grimm RA; Greenberg N; Popovic ZB; Cho L; Desai MY; Nissen SE; Kapadia SR; Svensson LG; Griffin BP; Cheng F; Collier P
    Am J Cardiol; 2020 Dec; 137():118-124. PubMed ID: 32991858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology: where do we stand for in Belgium?
    Lancellotti P; De Pauw M; Claeys M
    Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.